Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

406

Full text

350

Free full text

132

Publication Types

Journal Article

411

Randomized Controlled Trial

223

Research Support, Non-U.S. Gov't

217

Clinical Trial

Review

Comparative Study

Multicenter Study

Research Support, N.I.H., Extramural

Controlled Clinical Trial

Clinical Trial, Phase III

Meta-Analysis

Systematic Review

Research Support, U.S. Gov't, Non-P.H.S.

Research Support, U.S. Gov't, P.H.S.

Case Reports

Clinical Trial, Phase IV

Observational Study

Clinical Trial, Phase II

Comment

Letter

Consensus Development Conference

Clinical Trial Protocol

Editorial

Validation Study

Network Meta-Analysis

News

Publication Year

From

Quick links

Individual year

2026

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

2005

2004

2003

2002

2001

2000

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Fenofibrate""[mesh_terms]

417 Results

Searching titles within these results

Fenofibric acid for hyperlipidemia.

Syed M Mohiuddin, Manu Kaushik, Alok Saurav

Expert opinion on pharmacotherapy 2012;13(5):717-22

Full Text

Abstract

Should we start all patients with diabetic retinopathy on fenofibrates?

Satish Thomas, Gurvinder Kaur, Thomas Mathew, Jency M Koshy, Jacob Koshy

Middle East African journal of ophthalmology 2014;20(4):309-14

Free Full Text

Abstract

Fenofibrate: a review of its use in dyslipidaemia.

Gillian M Keating, Kate McKeage

Drugs 2011;71(14):1917-46

Full Text

Abstract

Is fenofibrate a reasonable treatment for diabetic microvascular disease?

Cristina Hernández, Rafael Simó, Olga Simó-Servat

Current diabetes reports 2015;15(5):24

Full Text

Abstract

The effects of fenofibric acid alone and with statins on the prevalence of metabolic syndrome and its diagnostic components in patients with mixed dyslipidemia.

Harold E Bays, Eli M Roth, James M McKenney, Maureen T Kelly, Kamlesh M Thakker, Carolyn M Setze, Katie Obermeyer, Darryl J Sleep

Diabetes care 2010;33(9):2113-6

Free Full Text

Abstract

Oral therapies for diabetic retinopathy: Addressing an unmet need or a distant prospect?

Theo Empeslidis, Georgios D Panos, Konstantinos Balaskas, David Rp Almeida

The Journal of international medical research 2025;53(12):3000605251396715

Free Full Text

Abstract

Fenofibrate monotherapy-induced rhabdomyolysis in a patient with hypothyroidism: A rare case report and literature review.

Dawei Wang, Yanqiu Wang

Medicine 2018;97(14):e0318

Free Full Text

Abstract

A new perspective in the treatment of dyslipidemia : can fenofibrate offer unique benefits in the treatment of type 2 diabetes mellitus?

George Steiner

Treatments in endocrinology 2005;4(5):311-7

Full Text

Abstract

Ezetimibe plus fenofibrate: a new combination therapy for the management of mixed hyperlipidaemia?

Michel Farnier

Expert opinion on pharmacotherapy 2007;8(9):1345-52

Full Text

Abstract

An ounce of prevention. Drugs used to treat hyperlipidemia (Part 1).

Beatrice B Turkoski

Orthopedic nursing 2004;23(1):58-61

Full Text

Abstract

Lipids and Diabetic Retinopathy.

Lawrence Morse, Bobeck S Modjtahedi, Namrata Bose, Thanos D Papakostas, Demetrios G Vavvas, Amar U Kishan

Seminars in ophthalmology 2016;31(1-2):10-8

Full Text

Abstract

Reverse cholesterol transport fluxes.

Scott Turner, Marc Hellerstein

Current opinion in lipidology 2014;25(1):40-7

Full Text

Abstract

Risk of Venous Thromboembolism with Statins: Evidence Gathered via a Network Meta-analysis.

Oğuzhan Birdal, Mehmet Saygı, Remziye Doğan, Ozan Tezen, Ali Karagöz, İbrahim Halil Tanboğa

Balkan medical journal 2023;40(5):324-332

Free Full Text

Abstract

The effect of fibrates and other lipid-lowering drugs on plasma homocysteine levels.

Claus Luley, Jutta Dierkes, Sabine Westphal

Expert opinion on drug safety 2004;3(2):101-11

Full Text

Abstract

Fenofibrate: a review of its use in primary dyslipidaemia, the metabolic syndrome and type 2 diabetes mellitus.

Katherine F Croom, Gillian M Keating

Drugs 2007;67(1):121-53

Full Text

Abstract

Results: 1 – 15 / 417

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Fenofibrate""[mesh_terms]

Fenofibric acid for hyperlipidemia.

Should we start all patients with diabetic retinopathy on fenofibrates?

Fenofibrate: a review of its use in dyslipidaemia.

Is fenofibrate a reasonable treatment for diabetic microvascular disease?

The effects of fenofibric acid alone and with statins on the prevalence of metabolic syndrome and its diagnostic components in patients with mixed dyslipidemia.

Oral therapies for diabetic retinopathy: Addressing an unmet need or a distant prospect?

Fenofibrate monotherapy-induced rhabdomyolysis in a patient with hypothyroidism: A rare case report and literature review.

A new perspective in the treatment of dyslipidemia : can fenofibrate offer unique benefits in the treatment of type 2 diabetes mellitus?

Ezetimibe plus fenofibrate: a new combination therapy for the management of mixed hyperlipidaemia?

An ounce of prevention. Drugs used to treat hyperlipidemia (Part 1).

Lipids and Diabetic Retinopathy.

Reverse cholesterol transport fluxes.

Risk of Venous Thromboembolism with Statins: Evidence Gathered via a Network Meta-analysis.

The effect of fibrates and other lipid-lowering drugs on plasma homocysteine levels.

Fenofibrate: a review of its use in primary dyslipidaemia, the metabolic syndrome and type 2 diabetes mellitus.

Results for
""Fenofibrate""[mesh_terms]